Aminopyrrolidine compound

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S135000

Reexamination Certificate

active

08044068

ABSTRACT:
Disclosed is an aminopyrrolidine compound represented by the formula [I] or a pharmaceutically acceptable salt thereof. The compound or the salt is useful as a prophylactic/therapeutic agent for mode disorder such as depression, anxiety disorder, anorexia, cachexia, pain and drug dependence, whose action relies on the MC4receptor antagonistic effect.

REFERENCES:
patent: 7759336 (2010-07-01), Habashita et al.
patent: 2007/0191364 (2007-08-01), Braun et al.
patent: 2010/0261701 (2010-10-01), Kaneko et al.
patent: 2005-523237 (2005-08-01), None
patent: 03/028641 (2003-04-01), None
patent: WO2004052862 (2004-06-01), None
patent: 2005/047251 (2005-05-01), None
patent: 2006/021656 (2006-03-01), None
Caprathe et al., 2005, CAS: 142:430293.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Aminopyrrolidine compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminopyrrolidine compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminopyrrolidine compound will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4293299

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.